Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program. Shanton Pharma Denmark Finland France Germany Netherlands Sweden United Kingdom New Jersey Singapore

View original content:https://www.prnewswire.co.uk/news-releases/shanton-receives-fast-track-designation-from-us-fda-for-refractory-gout-program-302514010.html